Clinical Trial Update: The Fasting II Study [NA]

View source ↗

Summary

The Fasting II Study (NCT01792986) has completed, with results posted in 2017, involving diabetes and metabolic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Metabolic Diseases

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Diabetes, Metabolic Diseases | NA | Status: COMPLETED | Results posted: 2017-02-03